{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:01:12Z","timestamp":1793736072305,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,12,15]],"date-time":"2013-12-15T00:00:00Z","timestamp":1387065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00104-013-2642-5","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T12:57:43Z","timestamp":1386939463000},"page":"327-333","source":"Crossref","is-referenced-by-count":7,"title":["Chirurgische Eingriffe an Patienten mit Mastzell\u00fcberaktivit\u00e4tserkrankung","Surgical interventions in patients with mast cell activation disease"],"prefix":"10.1007","volume":"85","author":[{"given":"B.","family":"Sido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.L.","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Homann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"Hertfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Molderings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,15]]},"reference":[{"key":"2642_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","volume":"29","author":"Alfter","year":"2009","unstructured":"Alfter K, K\u00fcgelgen I von, Haenisch B et al (2009) New aspects of liver abnormalities as part of the systemic mast cell activation syndrome. Liver Int 29:181\u2013186","journal-title":"Liver Int"},{"key":"2642_CR2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-010-1474-7","volume":"29","author":"Blanco","year":"2010","unstructured":"Blanco I, B\u00e9ritze N, Arg\u00fcelles M et al (2010) Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 29:1403\u20131412","journal-title":"Clin Rheumatol"},{"key":"2642_CR3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/ALN.0b013e3181bbd443","volume":"111","author":"Dewachter","year":"2009","unstructured":"Dewachter P, Mouton-Faivre C, Emala CW (2009) Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology 111:1141\u20131150","journal-title":"Anesthesiology"},{"key":"2642_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annfar.2008.09.022","volume":"28","author":"Dewachter","year":"2009","unstructured":"Dewachter P, Mouton-Faivre C, Cazala\u00e0 JB et al (2009) Mastocytosis and anaesthesia. Ann Fr Anesth Reanim 28:61\u201373","journal-title":"Ann Fr Anesth Reanim"},{"key":"2642_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1245707","volume":"49","author":"Frieling","year":"2011","unstructured":"Frieling T, Meis K, Kolck UW et al (2011) Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome. Z Gastroenterol 49:191\u2013194","journal-title":"Z Gastroenterol"},{"key":"2642_CR6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1398-9995.1995.tb02490.x","volume":"50","author":"Galli","year":"1995","unstructured":"Galli SJ, Costa JJ (1995) Mast-cell-leukocyte cytokine cascades in allergic inflammation. Allergy 50:851\u2013862","journal-title":"Allergy"},{"key":"2642_CR7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0952-8180(90)90063-9","volume":"2","author":"Greenblatt","year":"1990","unstructured":"Greenblatt EP, Chen L (1990) Urticaria pigmentosa: an anesthetic challenge. J Clin Anesth 2:108\u2013115","journal-title":"J Clin Anesth"},{"key":"2642_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","volume":"137","author":"Haenisch","year":"2012","unstructured":"Haenisch B, N\u00f6then MM, Molderings GJ (2012) Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics. Immunology 137:197\u2013205","journal-title":"Immunology"},{"key":"2642_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.lfs.2013.01.010","volume":"92","author":"Haenisch","year":"2013","unstructured":"Haenisch B, Huber M, Wilhelm T et al (2013) Investigations into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling. Life Sci 92:345\u2013351","journal-title":"Life Sci"},{"key":"2642_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1024\/0040-5930\/a000174","volume":"68","author":"Henzen","year":"2011","unstructured":"Henzen C (2011) Nebennierenrindeninsuffizienz \u2013 Abkl\u00e4rung und Therapie im klinischen Alltag. Ther Umsch 68:337\u2013343","journal-title":"Ther Umsch"},{"key":"2642_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejphar.2012.12.003","volume":"700","author":"Hoffmann","year":"2013","unstructured":"Hoffmann K, Altarcheh Xifro R, Hartweg JL et al (2013) Inhibitory effects of benzodiazepines on the adenosine A2B receptor-mediated secretion of interleukin-8 in human mast cells. Eur J Pharmacol 700:152\u2013158","journal-title":"Eur J Pharmacol"},{"key":"2642_CR12","first-page":"544","volume":"Klin","author":"Homann","year":"2010","unstructured":"Homann J, Kolck UW, Ehnes A et al (2010) Die systemische Mastozytose \u2013 Standortbestimmung einer internistischen Erkrankung. Med Klin (Munich) 105:544\u2013553","journal-title":"Med"},{"key":"2642_CR13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1213\/00000539-198503000-00008","volume":"64","author":"Horrow","year":"1985","unstructured":"Horrow JC (1985) Protamine: a review of its toxicity. Anesth Analg 64:348\u2013361","journal-title":"Anesth Analg"},{"key":"2642_CR14","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ijcard.2009.04.026","volume":"137","author":"Ilhan","year":"2009","unstructured":"Ilhan E, G\u00fcven\u00e7 TS, Poyraz E et al (2009) Kounis Syndrome secondary to cefuroxime axetil use in an asthmatic patient. Int J Cardiol 137:e67\u2013e69","journal-title":"Int J Cardiol"},{"key":"2642_CR15","first-page":"337","volume":"23","author":"Kase","year":"2009","unstructured":"Kase K, Hua J, Yokoi H et al (2009) Inhibitory action of roxithromycin on histamine release and prostaglandin D2 production from beta-defensin 2-stimulated mast cells. Int J Mol Med 23:337\u2013340","journal-title":"Int J Mol Med"},{"key":"2642_CR16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00540-013-1563-2","volume":"27","author":"Klein","year":"2013","unstructured":"Klein NJ, Misseldine S (2013) Anesthetic considerations in pediatric mastocytosis: a review. J Anesth 27:588\u2013598","journal-title":"J Anesth"},{"key":"2642_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.12659\/PJR.883370","volume":"77","author":"Kun","year":"2012","unstructured":"Kun T, Jakubowski L (2012) Influence of MRI contrast media on histamine release from mast cells. Pol J Radiol 77:19\u201324","journal-title":"Pol J Radiol"},{"key":"2642_CR18","first-page":"13","volume":"35","author":"Li","year":"2006","unstructured":"Li F (2006) Pharmacologically induced histamine release: sorting out hypersensitivity reactions to opioids. Drug Ther Top 35:13\u201316","journal-title":"Drug Ther Top"},{"key":"2642_CR19","first-page":"1","volume":"18","author":"Liccardi","year":"2008","unstructured":"Liccardi G, Lobefalo G, Di Florio E et al (2008) Strategies for the prevention of asthmatic, anaphylactic and anaphylactoid reactions during the administration of anesthetics and\/or contrast media. J Investig Allergol Clin Immunol 18:1\u201311","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2642_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/205873920601900102","volume":"19","author":"Lucas","year":"2006","unstructured":"Lucas HJ, Brauch CM, Settas L et al (2006) Fibromyalgia \u2013 new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 19:5\u20139","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2642_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2143\/AC.60.3.2005015","volume":"60","author":"Mazarakis","year":"2005","unstructured":"Mazarakis A, Koutsojannis CM, Kounis NG et al (2005) Cefuroxime-induced coronary artery spasm manifesting as Kounis syndrome. Acta Cardiol 60:341\u2013345","journal-title":"Acta Cardiol"},{"key":"2642_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","volume":"4","author":"Molderings","year":"2011","unstructured":"Molderings GJ, Brettner S, Homann J et al (2011) Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol 4:10","journal-title":"J Hematol Oncol"},{"key":"2642_CR23","doi-asserted-by":"crossref","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","volume":"8","author":"Molderings","year":"2013","unstructured":"Molderings GJ, Haenisch B, Bogdanow M et al (2013) Familial occurrence of systemic mast cell activation disease. PLoS ONE 8:e76241","journal-title":"PLoS ONE"},{"key":"2642_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1460-9592.2002.00759.x","volume":"12","author":"Prosser","year":"2002","unstructured":"Prosser DP, Gompels M (2002) Anaphylactic shock due to cefuroxime in a patient taking penicillin prophylaxis. Paediatr Anaesth 12:73\u201375","journal-title":"Paediatr Anaesth"},{"key":"2642_CR25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH11-05-0351","volume":"106","author":"Seidel","year":"2011","unstructured":"Seidel H, Molderings GJ, Oldenburg J et al (2011) Bleeding diathesis in patients with mast cell activation disease. Thromb Haemost 106:987\u2013989","journal-title":"Thromb Haemost"},{"key":"2642_CR26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/09629350120102343","volume":"10","author":"Shimane","year":"2001","unstructured":"Shimane T, Asano K, Suzuki M et al (2001) Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro. Mediators Inflamm 10:323\u2013332","journal-title":"Mediators Inflamm"},{"key":"2642_CR27","first-page":"503","volume":"13","author":"Shimane","year":"1999","unstructured":"Shimane T, Asano K, Mizutani T et al (1999) Inhibitory action of roxithromycin on tumour necrosis factor-alpha production from mast cells in vitro. In Vivo 13:503\u2013506","journal-title":"In Vivo"},{"key":"2642_CR28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1076029607309173","volume":"14","author":"Sucker","year":"2008","unstructured":"Sucker C, Mansmann G, Steiner S et al (2008) Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis. Clin Appl Thromb Hemost 14:360\u2013364","journal-title":"Clin Appl Thromb Hemost"},{"key":"2642_CR29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"Valent","year":"2011","unstructured":"Valent P, Akin C, Arock M et al (2011) Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 157:215\u2013225","journal-title":"Int Arch Allergy Immunol"},{"key":"2642_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1478-811X-11-13","volume":"11","author":"Yousefi","year":"2013","unstructured":"Yousefi OS, Wilhelm T, Maschke-Neu\u00df K et al (2013) The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions. Cell Commun Signal 11:13","journal-title":"Cell Commun Signal"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-013-2642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-013-2642-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-013-2642-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T21:50:13Z","timestamp":1564955413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-013-2642-5"}},"subtitle":["Operationsrelevante Aspekte am Beispiel einer Cholezystektomie","Aspects relevant for surgery using the example of a cholecystectomy"],"short-title":[],"issued":{"date-parts":[[2013,12,15]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["2642"],"URL":"https:\/\/doi.org\/10.1007\/s00104-013-2642-5","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,15]]}}}